103844 Federal Register / Vol. 89, No. 244 / Thursday, December 19, 2024 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Meetings of the Advisory Committee 

on Training and Primary Care Medicine 

and Dentistry (ACTPCMD) 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, this 

notice announces that the Advisory 

Committee on Training in Primary Care 

Medicine and Dentistry (ACTPCMD or 

Committee) will hold public meetings 

for the 2025 calendar year (CY). 

Information about ACTPCMD, agendas, 

and materials for these meetings can be 

found on the ACTPCMD website at: 

https://www.hrsa.gov/advisorycommittees/primarycare-dentist. 

DATES: ACTPCMD meetings will be held 

on 

• March 27, 2025, 8 a.m.–5 p.m. Eastern 

Time (ET) and March 28, 2025, 8 

a.m.–2 p.m. ET 

• August 8, 2025, 10 a.m.–5 p.m. ET 

ADDRESSES: Meetings will be held inperson, by teleconference, and/or on a 

video conference platform. In-person 

meetings will be held at 5600 Fishers 

Lane, Rockville, Maryland, 20857. For 

updates on how the meetings will be 

held, instructions for joining the 

meeting, or any other updates, visit the 

ACTPCMD website 30 business days 

before the date of the meeting, at: 

https://www.hrsa.gov/advisorycommittees/primarycare-dentist/ 

meetings. 

FOR FURTHER INFORMATION CONTACT: 

Shane Rogers, Designated Federal 

Officer, Division of Medicine and 

Dentistry, Bureau of Health Workforce, 

HRSA, 5600 Fishers Lane, Room 

15N102, Rockville, Maryland, 20857; 

301–443–5260; or SRogers@hrsa.gov. 

SUPPLEMENTARY INFORMATION: 

ACTPCMD provides advice and 

recommendations on policy and 

program development and other matters 

of significance to the Secretary of of 

Health and Human Services (Secretary) 

concerning the medicine and dentistry 

activities authorized under section 747 

of the Public Health Service (PHS) Act, 

as it existed upon the enactment of 

Section 749 of the PHS Act in 1998, and 

is responsible for preparing and 

submitting an annual report to the 

Secretary and Congress describing the 

activities of the Committee, including 

findings and recommendations made by 

the Committee concerning activities 

authorized under section 747 of the PHS 

Act, as it existed upon the enactment of 

Section 749 of the PHS Act in 1998. In 

addition, ACTPCMD develops, 

publishes, and implements performance 

measures and guidelines for 

longitudinal evaluations for programs 

authorized under Part C of Title VII of 

the PHS Act, as well as recommends 

appropriation levels for programs under 

this part. 

Since priorities dictate meeting times, 

be advised that start times, end times, 

and agenda items are subject to change. 

For CY 2025 meetings, agenda items 

may include, but are not limited to: 

pathways, recruitment, and retention of 

American Indian health providers; 

health workforce diversity; community 

colleges; faculty shortages; and dental 

accreditation requirements; as well as 

discussions pertaining to policy, 

program development, and other 

matters of significance concerning 

medicine and dentistry activities 

authorized under the relevant sections 

of the PHS Act. Refer to the ACTPCMD 

website listed above for all current and 

updated information concerning the CY 

2025 ACTPCMD meetings, including 

agendas and meeting materials that will 

be posted 30 calendar days before the 

meeting. 

Members of the public will have the 

opportunity to provide comments. 

Public participants may submit written 

statements in advance of the scheduled 

meeting(s). Oral comments will be 

honored in the order they are requested 

and may be limited as time allows. 

Requests to submit a written statement 

or make oral comments to ACTPCMD 

should be sent to Shane Rogers using 

the contact information above at least 5 

business days before the meeting 

date(s). 

Individuals who need special 

assistance or another reasonable 

accommodation should notify Shane 

Rogers using the contact information 

listed above at least 10 business days 

before the meeting(s) they wish to 

attend. Since all in-person meetings will 

occur in a federal government building 

at 5600 Fishers Lane, Rockville, MD, 

20857, attendees must go through a 

security check to enter the building. 

Members of the public must notify the 

Designated Federal Officer of their 

intent to attend the in-person meeting 

10 business days before the meeting. 

Non-U.S. citizen attendees must notify 

the Designated Federal Officer of their 

planned attendance at least 20 business 

days prior to the meeting to facilitate 

their entry into the building. All 

attendees are required to present 

government-issued identification prior 

to entry. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2024–30073 Filed 12–18–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting of the National 

Institute of Biomedical Imaging and 

Bioengineering Special Emphasis Panel. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; P41 NCBIB Review 

G–SEP. 

Date: February 11–13, 2025. 

Time: 9:00 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Democracy II, Suite 920, 6707 Democracy 

Blvd., Bethesda, MD 20817 (Virtual Meeting). 

Contact Person: Yoon-Young Jang, Ph.D., 

Scientific Review Officer, National Institute 

of Biomedical Imaging and Bioengineering, 

National Institutes of Health, 6707 

Democracy Blvd., Bethesda, MD 20892, (301) 

451–3397, yoonyoung.jang@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, National Institute of 

Biomedical Imaging and Bioengineering, 

National Institutes of Health.) 

Dated: December 13, 2024. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–30080 Filed 12–18–24; 8:45 am] 

BILLING CODE 4140–01–P 


lotter on DSK11XQN23PROD with NOTICES1